Study on the Construction and Application of a Large Model Corpus for Pancreatic Cancer Based on Real Clinical Cases
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Study ID
- NCT07713823
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pancreatic Cancer
- Pancreatic Cancer Metastatic
- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Resectable
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Combining retrospective observational research with artificial intelligence data engineering. Collecting historical electronic medical record data, and through data governance and annotation by artificial medical experts, constructing a structured knowledge base.
Key Dates
- First listed
- Jul 20, 2026
- Start date
- Aug 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2027
- Completion
- May 31, 2028
Study Design
- Enrollment
- 3,000 participants (estimated)
Primary Outcome Measure
3,000 Cases of Pancreatic Cancer Diagnosis and Treatment [ Time Frame: May 2028 ]
Central Contacts
- Long Jiang, MD18017317460
Find similar trials
Related Studies
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Pancreatic Adenocarcinoma Gene Environment Risk StudyRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic DiseaseRecruiting · Columbia University · New York, New York